COVID19 infection in a patient undergoing treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) with Ravulizumab

被引:0
作者
Sufana Shikdar
Azra Borogovac
Elabdallah Mohamad
Mohamad Khawandanah
机构
[1] University of Oklahoma Health Sciences Center,Department of Hematology/Oncology, Stephenson Cancer Center
[2] University of Oklahoma Medical Center (OUMC),Department of Internal Medicine
[3] University of Oklahoma Health Sciences Center,Hematology/Oncology fellow, Department of Medicine, Division of Hematology
来源
Thrombosis Journal | / 19卷
关键词
COVID19; Paroxysmal nocturnal hemoglobinuria; Complement inhibitor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 87 条
  • [21] Stern RM(undefined)undefined undefined undefined undefined-undefined
  • [22] Connell NT(undefined)undefined undefined undefined undefined-undefined
  • [23] Porfidia A(undefined)undefined undefined undefined undefined-undefined
  • [24] Valeriani E(undefined)undefined undefined undefined undefined-undefined
  • [25] Pola R(undefined)undefined undefined undefined undefined-undefined
  • [26] Porreca E(undefined)undefined undefined undefined undefined-undefined
  • [27] Rutjes AWS(undefined)undefined undefined undefined undefined-undefined
  • [28] Di Nisio M(undefined)undefined undefined undefined undefined-undefined
  • [29] Risitano AM(undefined)undefined undefined undefined undefined-undefined
  • [30] Mastellos DC(undefined)undefined undefined undefined undefined-undefined